Production of biologically active CXC chemokines by Lactococcus lactis: Evaluation of its potential as a novel mucosal vaccine adjuvant

Vaccine

Volumn 26, Issue 46, 2008, Pages 5778-5783

  Cortes Perez, Naima G ^a   Medina, Luis F da Costa ^a   Lefèvre, François ^a   Langella, Philippe ^a   Bermúdez Humarán, Luis G ^a  

^a CEMAGREF   (France)

Author keywords

Adjuvant; Chemokines; E7; HPV 16; IP 10; Lactococcus lactis; Mig; Mucosal vaccines

Indexed keywords

ALPHA CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON INDUCIBLE PROTEIN 10 MIG FUSION PROTEIN; HYBRID PROTEIN; MIG PROTEIN; PROTEIN E7; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; CHEMOTAXIS; CYTOKINE PRODUCTION; GENE FUSION; GENETIC ENGINEERING; HUMAN PAPILLOMAVIRUS TYPE 16; LACTOCOCCUS LACTIS; LEUKOCYTE MIGRATION; LYMPHOID ORGAN; NONHUMAN; PLASMID; PRIORITY JOURNAL; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY FORMATION; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; DNA, BACTERIAL; ESCHERICHIA COLI; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOCOCCUS LACTIS; MICE; MICE, INBRED C57BL; PLASMIDS; PROTEIN ENGINEERING;

EID: 53449089593     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.044     Document Type: Article

References (40)

1. Moser B., and Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2 (2001) 123-128
2. Farber J.M. HuMig: a new human member of the chemokine family of cytokines. Biochem Biophys Res Commun 192 (1993) 223-230
3. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61 (1997) 246-257
4. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18 (2000) 217-242
5. Streiter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270 (1995) 27348-27357
6. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 1217
7. Luster A.D., and Leder P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med 178 (1993) 1057-1065
8. Palmer K., Hitt M., Emtage P.C., Gyorffy S., and Gauldie J. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity. Gene Ther 8 (2001) 282-290
9. Hanniffy S., Wiedermann U., Repa A., Mercenier A., Daniel C., Fioramonti J., et al. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol 56 (2004) 1-64
10. Wells J.M., and Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6 (2008) 349-362
11. Steidler L., Wells J.M., Raeymaekers A., Vandekerckhove J., Fiers W., and Remaut E. Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl Environ Microbiol 61 (1995) 1627-1629
12. Steidler L., Robinson K., Chamberlain L., Schofield K.M., Remaut E., Le Page R.W., et al. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 66 (1998) 3183-3189
13. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 (2000) 1352-1355
14. Bermúdez-Humarán L.G., Langella P., Commissaire J., Gilbert S., Le Loir Y., L'Haridon R., et al. Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis. FEMS Microbiol Lett 224 (2003) 307-313
15. Bermúdez-Humarán L.G., Langella P., Cortes-Perez N.G., Gruss A., Tamez-Guerra R.S., Oliveira S.C., et al. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun 71 (2003) 1887-1896
16. Bermúdez-Humarán L.G., Nouaille S., Zilberfarb V., Corthier G., Gruss A., Langella P., et al. Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. Appl Environ Microbiol 73 (2007) 5300-5307
17. Bermúdez-Humarán L.G., Cortes-Perez N.G., L'Haridon R., and Langella P. Production of biological active murine IFN-gamma by recombinant Lactococcus lactis. FEMS Microbiol Lett 280 (2008) 144-149
18. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
19. Langella P., Le Loir Y., Ehrlich S.D., and Gruss A. Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis. J Bacteriol 175 (1993) 5806-5813
20. Bermúdez-Humarán L.G., Langella P., Miyoshi A., Gruss A., Guerra R.T., Montes de Oca-Luna R., et al. Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microbiol 68 (2002) 917-922
21. Kuipers O.P., de Ruyter P.G., Kleerebezen M., and de Vos W.M. Quorum sensing-controlled gene expression in lactic acid bacteria. J Biotechnol 64 (1998) 15-21
22. Bertho N., Adamski H., Toujas L., Debove M., Davoust J., and Quillien V. Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction. Blood 106 (2005) 1734-1741
23. Padovan E., Spagnoli G.C., Ferrantini M., and Heberer M. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J Leukoc Biol 71 (2002) 669-676
24. Ruehlmann J., Xiang M.R., Niethammer A.G., Ba Y., Pertl U., Dolman C.S., et al. MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. Cancer Res 61 (2001) 8498-8503
25. Cortes-Perez N.G., Bermúdez-Humarán L.G., Le Loir Y., Rodriguez-Padilla C., Gruss A., Saucedo-Cárdenas O., et al. Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol Lett 229 (2003) 37-42
26. Cortes-Perez N.G., Lefèvre F., Corthier G., Adel-Patient K., Langella P., and Bermúdez-Humarán L.G. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 25 (2007) 6581-6588
27. Feltkamp M.C., Vreugdenhil G.R., Vierboom M.P., Ras E., van der Burg S.H., ter Schegget J., et al. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur J Immunol 25 (1995) 2638-2642
28. Tindle R.W., Fernando G.J., Sterling J.C., and Frazer I.H. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc Natl Acad Sci USA 88 (1991) 5887-5891
29. Bermúdez-Humarán L.G., Cortes-Perez N.G., Le Loir Y., Alcocer-González J.M., Tamez-Guerra R.S., de Oca-Luna R.M., et al. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol 53 (2004) 427-433
30. Bermúdez-Humarán L.G., Cortes-Perez N.G., Lefèvre F., Guimarães V., Rabot S., Alcocer-Gonzalez J.M., et al. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol 175 (2005) 7297-7302
31. Singh U.P., Singh S., Iqbal N., Weaver C.T., McGhee J.R., and Lillard Jr. J.W. IFN-gamma-inducible chemokines enhance adaptive immunity and colitis. J Interferon Cytokine Res 23 (2003) 591-600
32. Yoon H.A., Aleyas A.G., George J.A., Park S.O., Han Y.W., Lee J.H., et al. Modulation of immune responses induced by DNA vaccine expressing glycoprotein B of Pseudorabies Virus via coadministration of IFN-gamma-associated cytokines. J Interferon Cytokine Res 26 (2006) 730-738
33. Yoon H.A., Aleyas A.G., George J.A., Park S.O., Han Y.W., Kang S.H., et al. Differential segregation of protective immunity by encoded antigen in DNA vaccine against pseudorabies virus. Immunol Cell Biol 84 (2006) 502-511
34. Valosky J., Hishiki H., Zaoutis T.E., and Coffin S.E. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus. Clin Diagn Lab Immunol 12 (2005) 171-179
35. Magistrelli G., Gueneau F., Muslmani M., Ravn U., Kosco-Vilbois M., and Fischer N. Chemokines derived from soluble fusion proteins expressed in Escherichia coli are biologically active. Biochem Biophys Res Commun 334 (2005) 370-375
36. Cho H.J., Lee Y., Chang R.S., Hahm M.S., Kim M.K., Kim Y.B., et al. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli. Protein Expr Purif 60 (2008) 37-45
37. Le Loir Y., Azevedo V., Oliveira S.C., Freitas D.A., Miyoshi A., Bermúdez-Humarán L.G., et al. Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact 4 (2005) 2
38. Morello E., Bermúdez-Humarán L.G., Llull D., Solé V., Miraglio N., Langella P., et al. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol 14 1-3 (2008) 48-58
39. Mielcarek N., Alonso S., and Locht C. Nasal vaccination using live bacterial vectors. Adv Drug Deliv Rev 23 (2001) 55-69
40. van Asseldonk M., Rutten G., Oteman M., Siezen R.J., de Vos W.M., and Simons G. Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene 95 (1990) 155-160